Bob Coughlin (@bobcoughlin) 's Twitter Profile
Bob Coughlin

@bobcoughlin

Managing Director, Life Sciences @JLL, former @MassBio CEO. Public Speaker, Former MA House of Representatives, Patient Advocate, CF Dad, #PatientDriven

ID: 142299055

linkhttp://jll.com calendar_today10-05-2010 14:11:58

13,13K Tweet

6,6K Followers

1,1K Following

Bob Coughlin (@bobcoughlin) 's Twitter Profile Photo

Caris Life Sciences secures $168M in funding, boosting its total raised to $1.86B since 2018. Investment from top healthcare firms supports an expansion of the AI-driven precision medicine platform, advancing cancer care and drug development. prn.to/3GkYZjW

Bob Coughlin (@bobcoughlin) 's Twitter Profile Photo

Awakn Life Sciences announces potential acquisition by Solvonis Therapeutics, signaling industry consolidation in psychedelic therapeutics. Deal could accelerate development of innovative mental health treatments, pending shareholder approval. bit.ly/42RRJVs

Bob Coughlin (@bobcoughlin) 's Twitter Profile Photo

Healthcare professionals embrace AI as the key to reducing burnout and streamlining admin tasks. The survey shows strong support for AI adoption, with a focus on ethical implementation and collaborative decision-making to transform patient care. bit.ly/3Gu5fpG

Bob Coughlin (@bobcoughlin) 's Twitter Profile Photo

23 years ago this guy entered the world. Cystic Fibrosis also became part of our lives. It's been a wild ride with lots of uknowns. But what we do know now is that when you team up with amazing people you can change the world. Bobby, thanks for showing us the meaning of grit,

23 years ago this guy entered the world.  Cystic Fibrosis also became part of our lives. It's been a wild ride with lots of uknowns.  But what we do know now is that when you team up with amazing people you can change the world. Bobby, thanks for showing us the meaning of grit,
Bob Coughlin (@bobcoughlin) 's Twitter Profile Photo

This #NationalNursesWeek, JLL honors nurses everywhere. We’re continuously inspired by your dedication to patients and communities everywhere. #ThePowerOfNurses bit.ly/3SnTjbD

Bob Coughlin (@bobcoughlin) 's Twitter Profile Photo

Basil Systems raises $11.5M for AI-driven life sciences intelligence platform. With 600 M+ indexed records, it helps pharma and medtech firms make faster decisions. Top companies use it to unify regulatory, clinical, and post-market data. bwnews.pr/4j7CnkQ

Bob Coughlin (@bobcoughlin) 's Twitter Profile Photo

ODU breaks ground on the $184M Biological Sciences Building, a 162,586 sq ft, 5-story facility, to open in spring 2028. Features cutting-edge labs, classrooms, and research spaces—the largest capital project in university history. bit.ly/3RY8IPJ

Bob Coughlin (@bobcoughlin) 's Twitter Profile Photo

Elemental Machines expands partnership with LabCentral, providing $590,000 in intelligent lab monitoring across six Cambridge sites. The collaboration equips 125+ biotech startups with real-time environmental tracking and operational tools. bwnews.pr/3SZMzRt

Bob Coughlin (@bobcoughlin) 's Twitter Profile Photo

FDA and EMA accelerate AI integration into regulatory processes, with FDA deploying generative AI by June 2025 that reduces 3-day reviews to minutes. Despite efficiency promises, questions remain about data security. bit.ly/3HhQp5W

Boston Business Journal (@bosbizjournal) 's Twitter Profile Photo

Susan Windham-Bannister, founding CEO of the Massachusetts Life Sciences Center, was a key architect of the state's effort to become the world leader in the sector. Recently she reflected on how it happened and what's next. bizjournals.com/boston/news/20…

Bob Coughlin (@bobcoughlin) 's Twitter Profile Photo

Synthetic biology offers revolutionary solutions while facing complex ethical challenges—from defining the moral status of engineered organisms to ensuring equitable access and avoiding environmental risks. bit.ly/4jN9vhW

Bob Coughlin (@bobcoughlin) 's Twitter Profile Photo

Biomanufacturing investments surge with $ 270 B+ planned as lab leasing slows amid economic uncertainties, per JLL. Pharma reshoring, shrinking inventory, and preference for prime locations shape evolving life sciences real estate. bit.ly/4kTgqYg

Bob Coughlin (@bobcoughlin) 's Twitter Profile Photo

TMRW Life Sciences acquires Cryogatt Systems' RFID patent portfolio to enhance digital specimen management for fertility clinics, expanding sperm storage solutions and bringing advanced tracking capabilities to existing cryostorage systems. prn.to/3HY5R7J

Bob Coughlin (@bobcoughlin) 's Twitter Profile Photo

Boston's Longwood Medical Area is set to expand with a new cancer hospital! Approved by the Boston Planning Department, the 300-bed facility will enhance inpatient care, create jobs, and improve community spaces like Joslin Park. bit.ly/3G5hHfK

Bob Coughlin (@bobcoughlin) 's Twitter Profile Photo

Innovation geographies are reshaping life sciences portfolios! Pharmaceutical, biotech, & medical device companies must rethink location strategies to access talent, resources, & collaboration. bit.ly/4eCKAwp

Bob Coughlin (@bobcoughlin) 's Twitter Profile Photo

JLL reports signs of recovery in Boston's lab market in Q2 2025! Demand doubled to 2.05M sq ft, and leasing activity surged. While rents are still down, pre-leasing is up, signaling a potential market rebalancing. bit.ly/3IyKg6g

Bob Coughlin (@bobcoughlin) 's Twitter Profile Photo

Unispace survey: US life science leaders are confident in current labs but wary of funding future expansion. Innovation drivers: digital integration, flexibility, collaboration, and sustainability. bit.ly/4kPhueU

Bob Coughlin (@bobcoughlin) 's Twitter Profile Photo

Oklahoma is building a biomanufacturing base! Investments in biotech diversify the economy and attract talent through hands-on training and partnerships with Wheeler Bio. bit.ly/4fcSbSH

Bob Coughlin (@bobcoughlin) 's Twitter Profile Photo

Beyond GenAI: Agentic AI transforms pharma manufacturing with autonomous decision-making and execution. These specialized agents optimize labs, accelerate production and strengthen supply chains while humans focus on innovation. bit.ly/4ffpXa9